Q3 2012 Earnings Call
April 04, 2012 4:30 pm ET
Bob Jones -
Joseph M. DeVivo - Chief Executive Officer, President and Director
D. Joseph Gersuk - Chief Financial Officer, Chief Accounting Officer, Executive Vice President and Treasurer
Matthew Hewitt - Craig-Hallum Capital Group LLC, Research Division
Jamar Ismail - Canaccord Genuity, Research Division
Jayson T. Bedford - Raymond James & Associates, Inc., Research Division
Charles Croson - Sidoti & Company, LLC
Robert M. Goldman - CL King & Associates, Inc.
Larry Haimovitch - Haimovitch Medical Technology Consultants
Good day, ladies and gentlemen. Thank you for standing by. Welcome to the AngioDynamics Third Quarter Fiscal 2012 Financial Earnings Conference Call. [Operator Instructions] This conference is being recorded today, Wednesday, April 4, 2012. I would now like to turn the conference over to Mr. Bob Jones of EVC Group. Please go ahead.
Thank you, Alicia, and thank you everyone for joining us today for the AngioDynamics conference call to review the results of the fiscal 2012 third quarter, which ended on February 29, 2012.
The news release announcing the results crossed the wire this afternoon after the market close and are available on the AngioDynamics website. The call is being broadcast live on the web at www.angiodynamics.com.
A replay of the call will be also archived on the AngioDynamics website. To access both the website and the archived replay, go to the Investors section under Events and Presentations.
Before we get started, during the course of this conference call, the company will make projections and forward-looking statements regarding future events, including statements about revenue and earnings for fiscal 2012.